Evidence map›Paper›PMID 31705378›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020

Photobiomodulation effects on head and neck squamous cell carcinoma (HNSCC) in an orthotopic animal model.

Andrei Barasch, Hongyan Li, Vinagolu K Rajasekhar, Judith Raber-Durlacher, Joel B Epstein, James Carroll, Adriana Haimovitz-Friedman

Open access · greenAbstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Photobiomodulation therapy for mitigating severity of radiodermatitis in cancer patients undergoing radiotherapy: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Andrei BaraschDepartment of Medicine, Weil Cornell Medical College, 1300 York Ave, New York, NY, 10065, USA. barasaff@cs.com.ORCID http://orcid.org/0000-0002-8142-2744
Hongyan LiMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Vinagolu K RajasekharMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Judith Raber-DurlacherAcademic Centre for Dentistry Amsterdam, University of Amsterdam and VU University, and University Medical Centers, location AMC, Amsterdam, The Netherlands.
Joel B EpsteinCedars-Sinai Health System, Los Angeles and City of Hope Cancer Center, Duarte, CA, USA.
James CarrollThor Photomedicine Ltd, Chesham, UK.
Adriana Haimovitz-FriedmanMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Memorial Sloan Kettering Cancer Center · USCity Of Hope National Medical Center · USCornell University · USUniversity of Amsterdam · NL

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundPhotobiomodulation (PBM) has shown efficacy in preventing and treating cancer therapy-induced mucositis and dermatitis. However, there is contradictory information regarding the effect of PBM on (pre)malignant cells, which has led to questions regarding the safety of this technique. We address this issue using an orthotopic mouse model (Cal-33) with human squamous cell carcinoma of the oral cavity.

methodsMice with actively growing orthotopic Cal-33 head and neck carcinoma tumors were divided into 4 groups: control, PBM only, radiation therapy (RT) only, and PBM + RT. We performed three experiments: (1) PBM at 660 nm, 18.4 J/cm

resultsAnimals treated with RT survived significantly longer and had significantly smaller tumor volume when compared with the control and PBM-only treatment groups. No significant differences were noted between the RT alone and PBM + RT groups in any of the experiments.

conclusionOur results suggest that PBM at the utilized parameters does not provide protection to the tumor from the killing effects of RT.

Indexed as

AnimalsCell Line, TumorDermatitisDisease Models, AnimalHumansLow-Level Light TherapyMiceMice, NudeMice, SCIDMucositisNeoplasm TransplantationRadiotherapySquamous Cell Carcinoma of Head and NeckStomatitisTransplantation, HeterologousHead and neck cancerOrthotopic mouse modelPhotobiomodulationRadiation therapy

Identifiers

PMID31705378
PMCPMC7682488
OpenAlexW2984621489

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.